Abstract
Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy, average survival of these patients is 3-5 years. All of the long term survivors of CML have been treated patients. Here we are reporting on a long term survivor (more than 10 years) without treatment.
Keywords
Fulltext
The full text of this article is available on PDF
Copyright
© 2002, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.